Cantidad de paquete: 1000500-250 gr
EClinicalMedicine , 69, 102475102475
Identification of DPP4/CTNNB1/MET as a theranostic signature of thyroid cancer and evaluation of the therapeutic potential of sitagliptin
coli strain NCTC 13846 with an MCR-1-mediated colistin resistance
Major Ingredients Galactomyces Ferment Filtrate, Glycerin, Cetyl Ethylhexanoate, Propanediol, Dicaprylyl Carbonate, 1,2-Hexanediol, Betaine, Cetearyl Alcohol, Polyglyceryl-10 Laurate, Methyl Trimethicone, Silica, Cetearyl Olivate, Panthenol, Phenyl Trimethicone, Potassium Cetyl Phosphate, Water, Sorbitan Olivate, Bisabolol, Ammonium Polyacryloyldimethyl Taurate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Dipropylene Glycol, Squalane, Laminaria Japonica Extract, Eclipta Prostrata Leaf Extract, 3-O-Ethyl Ascorbic Acid, Glutathione, Ethylhexylglycerin, Fragrance, Lavandula Angustifolia (Lavender) Oil, Coptis Japonica Root Extract, Xanthan Gum, Butylene Glycol, Adenosine, Fructooligosaccharides, Sorbitan Isostearate, T-Butyl Alcohol, Hydrogenated Lecithin, Beta-Glucan, Hydrolyzed Hyaluronic Acid, Ascorbic Acid, Tocopherol, Allantoin, Ceramide NP, Oryza Sativa (Rice) Bran Oil, Oryza Sativa (Rice) Bran Extract, Glyceryl Stearate, Phytosphingosine, Cholesterol, Ceramide AP, Ceramide AS, Ceramide NS, Caprylyl Glycol, Ceramide NG, Ceramide EOP, Linalool, Limonene Ingredients subject to change at manufacturer's discretion
